Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

× No keyword cloud information.

26 in total

Review 1. Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias.

Authors: D C Harrison; J W Fitzgerald; R A Winkle
Journal: N Engl J Med Date: 1976-02-12 Impact factor: 91.245

2. Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Authors: A J Wood; P Bolli; F O Simpson
Journal: Br J Clin Pharmacol Date: 1976-02 Impact factor: 4.335

3. Prazosin: severe side effects are dose-dependent.

Authors: C Rosendorff
Journal: Br Med J Date: 1976-08-28

4. Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors: G L Noel; H K Suh; J G Stone; A G Frantz
Journal: J Clin Endocrinol Metab Date: 1972-12 Impact factor: 5.958

5. Pharmacological studies with some new antihypertensive aminoquinazolines.

Authors: A Scriabine; J W Constantine; H J Hess; W K McShane
Journal: Experientia Date: 1968-11-15

6. Prazosin: the first-dose phenomenon.

Authors: R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal: Br Med J Date: 1976-11-27

7. Prazosin: biochemistry and structure-activity studies.

Authors: H J Hess
Journal: Postgrad Med Date: 1975-11 Impact factor: 3.840

8. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.

Authors: R Massingham; M L Hayden
Journal: Eur J Pharmacol Date: 1975-01 Impact factor: 4.432

9. Physiologic evaluation of a new antihypertensive agent: prazosin HCl.

Authors: M C Koshy; D Mickley; J Bourgiognie; M D Blaufox
Journal: Circulation Date: 1977-03 Impact factor: 29.690

10. Synthesis and identification of the major metabolites of prazosin formed in dog and rat.

Authors: T H Althuis; H J Hess
Journal: J Med Chem Date: 1977-01 Impact factor: 7.446

14 in total

1. Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Authors: M G Scott; A H Deering; M T McMahon; D W Harron; R G Shanks
Journal: Eur J Clin Pharmacol Date: 1989 Impact factor: 2.953

2. Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics and first dose effect of prazosin.

Authors: M S Lennard; J C McGourty; J H Silas
Journal: Br J Clin Pharmacol Date: 1988-02 Impact factor: 4.335

3. Profound hypotension after the first dose of ketanserin.

Authors: P C Waller; H A Cameron; L E Ramsay
Journal: Postgrad Med J Date: 1987-04 Impact factor: 2.401

4. Electrophysiological effects of felodipine.

Authors: M Been; P W Macfarlane; W S Hillis
Journal: Drugs Date: 1985 Impact factor: 9.546

5. Alpha-blockers and converting enzyme inhibitors.

Authors: P C Rubin; J L Reid
Journal: Br Med J (Clin Res Ed) Date: 1983-04-09

6. The influence of repeated administration of prazosin on its hypotensive effect and on renin release in conscious dogs. A comparison with urapidil.

Authors: A Beck; O Kraupp; S Bacher; R Seitelberger; G Raberger
Journal: Basic Res Cardiol Date: 1984 Sep-Oct Impact factor: 17.165

7. The effect of a single oral dose of prazosin on venous reflex response, blood pressure and pulse rate in normal volunteers.

Authors: G J Schapel; W H Betts
Journal: Br J Clin Pharmacol Date: 1981-12 Impact factor: 4.335

Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.